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Pathology of Podocytopathies 
Causing Nephrotic Syndrome  
in Children
Sarangarajan Ranganathan*
Department of Pathology, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
Nephrotic syndrome (NS) in children includes a diverse group of diseases that range 
from genetic diseases without any immunological defects to causes that are primarily 
due to immunological effects. Recent advances in molecular and genomic studies have 
resulted in a plethora of genetic defects that have been localized to the podocyte, the 
basic structure that is instrumental in normal filtration process. Although the disease 
can manifest from birth and into adulthood, the primary focus of this review would be to 
describe the novel genes and pathology of primary podocyte defects that cause NS in 
children. This review will restrict itself to the pathology of congenital NS, minimal change 
disease (MCD), and its variants and focal segmental glomerulosclerosis (FSGS). The two 
major types of congenital NS are Finnish type characterized by dilated sausage shaped 
tubules morphologically and diffuse mesangial sclerosis characterized by glomeruloscle-
rosis. MCD has usually normal appearing biopsy features on light microscopy and needs 
electron microscopy for diagnosis, whereas FSGS in contrast has classic segmental 
sclerosing lesions identified in different portions of the glomeruli and tubular atrophy. This 
review summarizes the pathological characteristics of these conditions and also delves 
into the various genetic defects that have been described as the cause of these primary 
podocytopathies. Other secondary causes of NS in children, such as membranoprolifer-
ative and membranous glomerulonephritis, will not be covered in this review.
Keywords: congenital nephrotic syndrome, Finnish type, diffuse mesangial sclerosis, minimal change disease, 
focal segmental glomerulosclerosis, C1q nephropathy
iNTRODUCTiON
The kidney is the main organ of filtration in the body, and the daily protein loss is only a small portion 
of the total protein ingested. Nephrotic syndrome (NS) is characterized by heavy proteinuria that 
exceeds 1.66 g/1.73 m2/day in children, edema, hypoalbuminemia, and hyperlipidemia (1). Although 
the causes of NS are many and diverse, it is a frequent cause of renal disease in children with an 
annual incidence of about 2 to 7 children per 100,000 (1). The International Study of Kidney Disease 
in Children lists minimal change disease (MCD) as the commonest cause of primary NS in children 
affecting 77% of the children followed by focal segmental glomerulosclerosis (FSGS) at about 8% 
followed by membranoproliferative glomerulonephritis (MPGN) and membranous glomerulone-
phritis (2). The causes of NS also vary to some extent with the age of presentation with the congenital 
forms more directly associated with specific genetic defects and those appearing in later childhood 
related more often to secondary causes.
TABLe 1 | Causes of nephrotic syndrome in children.
Genetic
Congenital nephrotic syndrome of Finnish type
Diffuse mesangial sclerosis (DMS)
Isolated DMS
Part of Denys–Drash syndrome
Epidermolysis bullosa associated
Steroid-resistant nephrotic syndrome
Familial focal segmental glomerulosclerosis (FSGS)
infectious causes
Congenital infections including syphilis, toxoplasmosis, and HIV
Cytomegalovirus
HIV-associated nephropathy
idiopathic
Minimal change nephropathy
Focal segmental glomerulosclerosis
Diffuse mesangial hypercellularity
Membranous glomerulonephritis
Membranoproliferative GN (MPGN) (NS may predominate or with nephritic 
syndrome)
Others
Lupus nephropathy
IgA nephropathy
Drugs
Malignancies
Hemolytic uremic syndrome (HUS)
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PATHOPHYSiOLOGY OF NS
The primary defect in NS is loss of proteins in the kidney. Although 
lack of tubular reabsorption could lead to proteinuria, NS range 
proteinuria usually implies permeability defects in the glomeru-
lar membrane that results in this excessive protein loss. This leads 
to albuminuria and hence the associated hypoalbuminemia and 
edema, the two main manifestations of NS. The hyperlipidemia is 
usually due to the increased lipoprotein synthesis induced by the 
hypoalbuminemia, and this may lead to increased platelet aggre-
gation and thrombosis, one of the complications of NS. The loss of 
other proteins, minerals, and vitamins with the proteinuria may 
also predispose to malnutrition and infections. The most dra-
matic advances for understanding the pathophysiology of NS has 
occurred in the area of podocyte biology and the structure of the 
slit diaphragm (3–5). The glomerular filtration barrier consists of 
the fenestrated capillary endothelium, the extracellular basement 
membrane, and the intercalated podocyte foot processes. NS is 
associated with the biopsy finding of effacement of podocyte foot 
processes. Effacement is characterized by flattening of the podo-
cyte, retraction of foot processes, and sometimes microvillous 
transformation. It has also been understood that MCNS and FSGS 
can be classified as podocytopathies, in which disruption of slit 
diaphragm and normal podocyte function can lead to proteinuria 
and glomerular disease. Details of the structure and mechanisms 
of podocyte injury and defects are beyond the scope of this article, 
and readers are directed to several reviews on podocytes (3–5).
CAUSeS OF NePHROTiC SYNDROMe  
iN CHiLDReN
The causes of NS show some variations depending on the age of the 
child with early onset NS usually representing primary genetic or 
idiopathic causes, such as congenital NS, due to any of the known 
genetic defects or MCD and less often FSGS (Table 1) (2, 6, 7). As the 
age increases, the ratio of MCD and FSGS may vary with secondary 
causes becoming more common in the second decade. Although 
NS may be the only presentation in children, often the condition is 
precipitated or can be seen as part of a nephritic syndrome. There is 
still some controversy on whether MCD and FSGS are related enti-
ties with MCD representing the early form of a disease and FSGS 
the late stage. This is especially so since there is often the finding 
of an early biopsy with MCD changes with refractory disease and 
a later biopsy showing features of FSGS. Also, while several genes 
have now been identified in MCD and FSGS, no distinct genetic 
defects have been found for these two diseases (7).
GeNeTiCS OF NS
The podocyte, as mentioned before, is the critical structure and has 
a critical role in pathogenesis of NS (Table 2; Figure 1). Podocytes 
form foot processes and slit diaphragms as part of normal devel-
opment. This leads to the expression of specific proteins, such as 
ZO-1, in the slit diaphragm and nephrin, podocin, and CD2AP 
(adhesion molecule CD2-associated protein) are expressed (5). 
Nephrin gene mutations cause Finnish-type nephropathy (7, 8). 
Other developmental genes involved in podocyte structure and 
function include Pax-2 and WT1. The WT1 gene mutation results 
in the Denys–Drash syndrome and Frasier syndrome. Podocin 
gene defects cause familial autosomal-recessive steroid-resistant 
NS in early childhood. The individual genetic defects are described 
further in the respective disease sections. It is critical to under-
stand the structure of the podocyte and the basement membrane 
with all its collagen to understand the genetic defects and their 
potential effect. Discovery of novel mutations has led to further 
understanding of the biology and prognosis of these diseases.
ROLe OF ReNAL BiOPSY iN  
DiAGNOSiS OF NS
In many instances, there may be no role for pathologist for 
diagnosis due to the ability to do genetic testing for individual 
mutations and due to the response to steroid therapy, but increas-
ing incidence of resistance to steroid therapy has increased the 
role of the pathologist in determining if FSGS is the cause of 
steroid resistance. Other causes for biopsy are presence of coexist-
ing nephritic syndrome and for determination of other causes 
of NS. All renal biopsies need triaging for adequacy to perform 
immunofluorescence and electron microscopy (EM). In view 
of the broad etiology and associated conditions, the pathologist 
very often has a critical role in guiding therapy in these patients. 
Routine histology warrants a PAS and silver stain for assessment 
of basement membranes and a Masson trichrome stain for 
assessment of fibrosis and glomerulosclerosis as well as vascular 
changes. The standard panel for IF includes IgG, IgA, IgM, C3, 
C4, C1q, and albumin with kappa and lambda where needed. EM 
is necessary for diagnosis in many instances.
TABLe 2 | Genetic causes of nephrotic syndrome.
Genes Location  
(if known)
Protein Significant clinical association
NPHS1 19q13.12 Nephrin CNS Finnish type
NPHS2 1q25.2 Podocin Steroid-resistant NS; rapidly progressive renal disease; FSGS
WT1 (NPHS4) 11p13 Wilms’ tumor 1 Denys–Drash syndrome; nephrotic syndrome–FSGS; Frasier syndrome
SMARCAL1 2q35 SW1/SNF related Schimke immunoosseous dysplasia
PLCE1 (NPHS3) 10q23.33 Phospholipase CE1 DMS, FSGS
PTPRO 12p12.3 Protein tyrosine phosphatase, receptor-type O Steroid-resistant NS
LAMB2 3p21.31 Laminin, beta-2 CNS with ocular abnormalities; Pierson syndrome
INF2 (FSGS 5) 14q32.33 Inverted formin 2 FSGS
COQ6 14q24.3 Coenzyme Q10 def, primary 6 Progressive NS in infancy with sensorineural deafness; FSGS, DMS
MYO1E (FSGS6) 15q21 Myosin 1E FSGS (AR)
TRPC6 (FSGS2) 11q22.1 Transient receptor potential cation channel, 
subfamily C, member 6
FSGS (AD)
COQ2 4q21.23 Coenzyme Q10 deficiency-1 Steroid-resistant NS
LMX1B 9q33.3 LIM homeobox transcription factor 1, beta Nail–patella syndrome
ADCK4 (NPHS9) 19q13.2 AARF domain-containing kinase 4 NS (AR)
PDSS2 6q21 Prenyl diphosphate synthese, subunit 2 NS
ACTN4 (FSGS1) 19q13.2 Alpha-actinin-4 FSGS
CD2AP (FSGS3) 6p12.3 CD2-associated protein FSGS
MYH9 22q13.1 Non-muscle myosin IIA heavy chain FSGS, collapsing glomerulopathy
FiGURe 1 | A diagrammatic representation of the basement membrane foot processes with the location of the most common genes implicated in 
nephrotic syndrome.
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PATHOLOGY OF COMMON CAUSeS  
OF NS iN CHiLDHOOD
Congenital Nephrotic Syndrome of  
Finnish Type
It is an autosomal-recessive disorder with an incidence of 
1:8200 births in Finland (9). It is also seen in North American 
and European populations and is a cause of congenital NS with 
prenatal presentation in many cases. Diagnosis has been made 
in utero by amniocentesis that shows elevated alpha-fetoprotein 
as early as 16–18  weeks gestation (10). It results in small for 
gestational age neonate with prematurity, deformities due to con-
tractures and an abnormally enlarged placenta. It results in heavy 
proteinuria in the neonatal period with selective proteinuria in 
FiGURe 2 | Histological panel for congenital nephrotic syndrome of Finnish type. (A) A photomicrograph showing a cluster of normal appearing glomeruli 
with dilated proximal tubules with proteinaceous contents (H&E 100×). (B) Another area from this resected renal specimen showing the varying shapes of the dilated 
proximal tubules, a characteristic feature of congenital NS (H&E 100×). (C) Another image from the opposite kidney showing the same morphological features with 
no segmental sclerosis evident at this time (H&E 100×).
FiGURe 3 | Histological images for diffuse mesangial sclerosis. (A) An image from another nephrectomy specimen showing the numerous dilated tubules 
with small occasional glomeruli (H&E 40×). (B) Higher magnification of the glomeruli showing a solidified appearance on light microscopy (H&E 200×). (C) A Jones 
silver stain highlighting the solidified loops with accentuation of the epithelial cells on the surface. No capillary loops are identified (Jones methanamine silver 200×). 
(D) A trichrome stain showing the mesangial sclerosis characteristic of this disease. Note again the prominent epithelial cells. Progressive disease leads to 
glomerular obsolescence and interstitial fibrosis seen in this image (Trichrome 200×).
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FiGURe 4 | Minimal change disease. (A) A photomicrograph showing normal appearing uniform sized glomeruli in the cortex (H&E 400×). (B) A silver stain 
showing the normal loops with accentuation of the epithelial cells (Jones 400×). (C) A low magnification image of a trichrome stain showing no glomerular or interstitial 
fibrosis (Trichrome 40×). (D) A negative immunofluorescence panel for immunoglobulins or C3 (Direct immunofluorescence 400×). (e,F) An electron micrograph image 
showing open capillary loops with effacement of foot processes better visualized in (F), which shows the diffuse fusion of foot processes [6200× (e) and 46,000× (F)].
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the early stages and more non-selective proteinuria in the later 
stages as the disease progresses. Most infants do not survive 
beyond 1 year of life, usually due to infections and sepsis related 
to loss of immunoglobulins. The gene for Finnish nephropathy 
(FN) is NPHS1 mapped to the long arm of chromosome 19 
(19q13.1) that codes for nephrin (7, 11, 12). Several nephrin 
mutations have now been identified. The typical mutations are 
a 2-bp deletion in exon 2 (Fin-major) or a nonsense mutation in 
exon 26 (Fin-minor). Renal biopsy shows normal glomeruli or 
some with mesangial hypercellularity, hyperlobulated capillary 
tufts, and some scarring. Microcystic dilatation of proximal and 
distal tubules is also seen, and there may be associated interstitial 
fibrosis and inflammation (Figure  2). Immunofluorescence is 
negative, whereas EM shows diffuse foot process effacement with 
or without villous transformation. Immunohistochemical stain 
for nephrin, now commercially available will show negative stain-
ing of podocyte. This stain helps in differentiating FN from other 
causes of congenital NS. Development of anti-nephrin antibodies 
and recurrence in allograft kidney has been reported (13).
Diffuse Mesangial Sclerosis
This is the second most common cause of congenital NS diag-
nosed on renal biopsy. Although the presentation is similar to 
that of FN, diffuse mesangial sclerosis (DMS) can present later up 
to 4 years of age. It presents with unremitting NS within the first 
9 months of life usually. Infants develop hypertension with rapid 
onset of renal failure. The combination of DMS, Wilms tumor, 
and male pseudohermaphroditism constitutes Denys–Drash syn-
drome (14). Other associations include cataract, strabismus, nys-
tagmus, myopia and aniridia, mental retardation, microcephaly, 
TABLe 3 | Common forms of familial FSGS.
Gene (protein 
effected)
inheritance Typical age 
of onset
Distinguishing clinical 
features
NPHS1 
(nephrin)
AR Infancy Congenital nephrotic syndrome 
(Finnish type); severe nephrosis 
leading to ESRD
NPHS2 
(podocin)
AR 3 months to 
5 years
10–20% of SRNS in children
WT1 (Wilms 
tumor 1)
AD Child Diffuse mesangial sclerosis/
FSGS ± Wilms tumor or 
urogenital lesions
PLCε1 
(phospholipase 
Cε1)
AR 4 months to 
12 years
Diffuse mesangial sclerosis/
FSGS
CD2AP (CD2-
associated 
protein)
AR <6 years Rre, progresses to ESRD
INF2 (inverted 
formin 2)
AD Teen/young 
adult
Mild nephrotic syndrome, but 
progressive CKD
ACTN4 
(α-actinin 4)
AD Any age Mild nephrotic syndrome may 
develop progressive CKD
TRPC6 AD Adult (age 
20–35 years)
Nephrotic, progressive CKD
tRNALeu(UUR) 
gene
Mitochondrial 
DNA
Adult May be associated deafness, 
diabetes, muscle problems, 
retinopathy (maternal 
inheritance)
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deafness, musculoskeletal abnormalities, and cleft palate. DMS is 
also part of the Galloway–Mowat syndrome, Pierson syndrome 
(LAMB2 mutations), and Frasier syndrome (7). It is caused by 
WT1 gene mutations in exon 8 or 9 (14). Frasier syndrome is 
usually caused by a splice variant mutation in exon 9 (15). The 
earliest light microscopic feature is increased mesangial matrix 
that is global and diffuse. There is a gradient of changes seen 
from the outer to the inner cortex with the most severe sclerosis 
being seen in the outer cortex, DMS in the mid zone and milder 
sclerosis in the inner zone (Figure 3). In some cases, prominent 
focal or global glomerulosclerosis may be seen. Podocytes may 
be prominent over the tufts. Severe tubulointerstitial damage 
with cysts and tubular ectasia may be seen. Immunofluorescence 
shows no immune deposits or non-specific mesangial IgM, 
C3, and C1q, whereas EM shows variable effacement of foot 
processes. Glomerular basement membrane lamellations and 
splitting similar to Alport’s syndrome may be seen. In late stages, 
there is widening of the BM with thickened capillary loops and 
finally a sclerotic glomerulus.
Minimal Change Disease
Minimal change disease is more common in boys than girls with a 
ratio of 2:1. Almost 80% of cases occur in children <6 years of age 
(median age 2.5 years) (1, 16). It can be idiopathic, secondary, or 
familial. The most common form is sporadic MCD that is usually 
steroid sensitive. The genes mutated in MCD include NPHS1 
and NPHS 2 (7). Mutations in the dysferlin gene have also been 
described. More recently, mutations in epithelial membrane pro-
tein 2 (EMP2) gene have been shown to cause childhood-onset 
NS. Crumbs homolog 2 (CRB2) defects have been associated with 
steroid-resistant NS. NPHS2 mutations have been associated with 
steroid resistance (17, 18).
Light microscopy usually shows normal glomeruli and 
tubules with the only change being prominence and swelling 
of visceral epithelial cells (2, 16). Patchy mild expansion of the 
mesangium may be seen in some cases (Figure 4). Histological 
finding of even a single glomerulus with segmental sclerosis, 
hyalinosis, or synechiae is enough to warrant a diagnosis of 
FSGS. Immunofluorescence is usually negative for any immune 
deposits, although there may be weak staining for IgM or C3 in 
a mesangial location in some cases. Albumin is positive within 
tubules reflecting the albuminuria. EM shows diffuse foot pro-
cess effacement with prominent villous transformation, directly 
correlating with the severity of proteinuria and less prominent 
and patchy following treatment. Although this is the usual 
pattern, variants with increased mesangial hypercellularity are 
described. Immature glomeruli may be seen with this mesangial 
hypercellularity variant. In those patients presenting with acute 
renal failure, acute tubular injury and interstitial inflammation 
may be seen. Tubular atrophy is, however, not a feature of MCD. 
In those cases where IF shows deposits, the most likely ones are 
IgM (IgM nephropathy) or C1q (C1q nephropathy). In those 
where IgA is the dominant immunoglobulin, coexistent IgA 
nephropathy must be considered (19). The differential diag-
nosis for MCD is FSGS and as mentioned earlier, presence of 
any of the glomerular changes or foci of tubular atrophy in the 
absence of typical FSGS lesion, should raise the possibility of 
FSGS. Foot process effacement is not specific to MCD and can 
be seen in any cause of severe proteinuria. The debate over C1q 
being a specific subtype is still open as more recent data seems 
to suggest that though the initial response to therapy is poorer 
in this group, the overall long-term outcome is not different 
from cases of MCD.
The diffuse mesangial hypercellularity variant of MCD defined 
by presence of more than four mesangial cells per mesangial 
region affecting at least 80% of the glomeruli is a rarer cause of NS 
in children (16, 20). These patients can present with hematuria 
and hypertension unlike classic MCD children. IF shows mainly 
IgM and C3 in the mesangium, whereas EM shows paramesangial 
deposits besides the diffuse foot process effacement. This variant 
is usually associated with increased initial resistance to steroid 
therapy, but the overall remission rates are similar to MCD.
IgM nephropathy is another unusual variant of MCD charac-
terized by at least 2+ staining intensity for IgM on IF (20). The 
distribution is mainly mesangial but could be membranous, but 
EM shows only a few small paramesangial deposits, suggesting 
that this deposition may be more of protein trapping rather than 
an immune complex disease. Initial steroid resistance is followed 
by remission (21).
Focal Segmental Glomerulosclerosis
Focal segmental glomerulosclerosis is defined by the presence 
of segmental sclerotic lesions within glomeruli causing NS. It 
is the cause of NS in about 10–20% of cases in children. There 
is an association with low birth weight infants, especially for 
secondary FSGS (22). The causes are manifold and include 
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primary idiopathic FSGS, genetic, and familial cases included 
under secondary FSGS, and secondary FSGS due to systemic 
diseases, which are more common in adults but can be seen in 
older children too (Table 3).
Primary (idiopathic) FSGS
This is the most common pattern of FSGS in children with 
a slight male preponderance and increased incidence in the 
African-American population (23). It presents with NS in 90% 
FiGURe 5 | Primary focal segmental glomerulosclerosis. (A,B) Photomicrographs showing two glomeruli with a segmental lesion characterized by obliteration 
of capillary loops with solidification and eosinophilia of the segment due to sclerosis (H&E 200×). (C,D) PAS stained sections showing a focal sclerosing lesion in a 
segment in (C) and in the perihilar region in (D) close to the vascular pole. Note again the preservation of capillary loops in other segments of the glomeruli (PAS 
200×). (e) A trichrome stain showing the perihilar zone of sclerosis as evidenced by the blue staining of that segment. Note also some fibrin deposition in that area 
(red) (Trichrome 200×). (F) Immunofluorescence showing strong staining for albumin in the tubules, a characteristic feature of nephrotic syndrome in general. Not 
shown is the associated IgG deposition (DIF 100×). (G,H) Two electron photomicrographs showing collapsed loops in the (H) with effacement of foot processes in 
both images. Typically, the foot process effacement may be segmental and over the sclerosed segments (EM 3400×).
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of cases but may present with renal insufficiency, hypertension, 
and hematuria in a proportion of cases. The histological variants 
described for FSGS include the classic or FSGS NOS variant, 
cellular variant, tip lesion, FSGS with mesangial hypercellularity, 
perihilar FSGS, and collapsing FSGS. Light microscopy for FSGS 
NOS is characterized by discrete segmental solidification of the 
glomerular tuft with a predilection for the juxtaglomerular region 
in the early stages of the disease. They commonly affect the vascu-
lar pole or the periphery of the tuft. The capillaries are occluded 
by acellular matrix material that produces intramembranous 
hyalinosis lesions highlighted as bright pink with a PAS stain 
and red with a trichrome stain, with progressive wrinkling of the 
membranes, development of adhesions and synechiae with the 
Bowman’s capsule with a prominence of visceral epithelial cells 
over this tuft (Figure 5). While focal lesions are the rule in early 
cases, with progression, glomerular obsolescence results. Tubular 
atrophy and interstitial fibrosis are evident in the vicinity of the 
sclerosed glomerulus involving the same nephron unit. Tubules 
contain protein resorption droplets and lipid droplets (24–26). 
IF usually shows focal and segmental granular IgM and C3, both 
within the membranes of the sclerosed segment and mesangium. 
Albumin will be noted in tubules. EM shows wrinkling and 
retraction of the glomerular basement membrane with accumu-
lation of hyaline. There is complete effacement of foot processes 
overlying the sclerotic region with podocyte hypertrophy and 
focal microvillus transformation. Effacement may be mild to 
severe in the adjacent non-sclerotic glomeruli but affects more 
than half the surface membrane.
FiGURe 6 | Secondary FSGS. (A) An image showing a biopsy with interstitial fibrosis, tubular atrophy, and a segmentally sclerosed glomerulus (H&E 100×). (B) 
PAS stain showing the extensive tubular atrophy (PAS 100×). (C) PAS stain showing two glomeruli, one larger than the other with the smaller one showing an area of 
sclerosis associated with epithelial cell proliferation in that area (PAS 200×). (D) A silver stain showing the segmental sclerosis in the perihilar region (Jones 200×). 
(e,F) Electron micrographs showing two images of the basement membranes with variable diameters showing prominent splitting of lamina densa with a basket 
weave appearance characteristic of hereditary nephritis, proven by collagen studies. Note also the microvillous transformation of foot processes and effacement in 
this patient with nephrotic range proteinuria (11,500×).
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Cellular FSGS
This variant is characterized on light microscopy by segmental 
hypercellularity resembling focal proliferative GN with areas of 
the tuft showing endocapillary proliferation with luminal oblit-
eration of capillaries, increased mesangial cells, and prominent 
increase in inflammatory cells, including neutrophils, foam cells, 
and monocytes, with marked podocyte hyperplasia giving the 
appearance of crescents (pseudocrescents). IF shows some IgM 
and C3, whereas EM shows no significant deposits but prominent 
foot process effacement with intact basement membranes.
Tip Lesion
This is characterized by proliferation of swollen podocytes and 
endocapillary proliferation with progressive obsolescence located 
at the tip of the tuft at the origin of the proximal tubule. As the 
lesion progresses, it results in a segmental scar in that area. There 
is associated tubular atrophy and interstitial fibrosis develops 
over time and may not be a feature in the early classic tip lesions. 
IF again shows IgM and C3, whereas EM resembles the cellular 
variant.
Primary FSGS with Mesangial Hypercellularity
In this variant, the histology reveals classic segmental sclerosing 
lesions associated with podocyte hyperplasia but with the associ-
ated finding of mesangial hypercellularity in the non-sclerotic 
glomeruli. The IF shows a diffuse presence of IgM and C3 in 
the mesangium of non-sclerotic glomeruli and in the zone of 
sclerosis. The EM shows extensive foot process effacement with 
no electron dense deposits.
Familial FSGS
Familial FSGS probably accounts for about 20% of cases of FSGS 
and can manifest at any age (27). The incidence increases to two-
thirds of cases discovered in the first year of life. Several newer 
mutations have now been described to be associated with FSGS 
pattern of injury including mutations in the NPHS2 gene (podocin 
defect, chromosome 1q25-31), with an autosomal-recessive mode 
of inheritance, actinin 4 defect (ACTN4, autosomal dominant), 
TRPC6 (transient receptor potential cation channel, subfamily C, 
member 6), and CD2AP (7, 28, 29). Of these the podocin defect 
is the most common and can be detected by immunohistochem-
istry that shows loss of podocin staining. Other mutations and 
their known associations are shown in Table 3.
Secondary FSGS
Segmental sclerosis can occur commonly in other diseases, not 
only in adults but also in children. The most common pediatric 
diseases that can have a component of associated NS in addition 
to a nephritic picture with histological evidence of FSGS include 
IgA nephropathy, Hereditary nephritis (Alport’s syndrome), and 
lupus nephritis The histological picture and immunofluorescence 
usually reveal the underlying disease, for example, mesangial 
hypercellularity and mesangial IgA in IgA nephropathy, full-
house pattern in lupus nephritis, and thin basement membrane 
FiGURe 7 | Collapsing glomerulopathy. (A,B) H&E images showing a low power and higher magnification appearance of a glomerulus with prominent epithelial 
cells and closed capillary loops better visualized on special stains (H&E 100× and 200×). (C) A PAS stain showing the collapsed cords of basement membranes 
with exuberant epithelial cell proliferation that seems to “choke” the capillary loops (PAS 400×). (D) A silver stain showing another glomerulus with wrinkling of the 
basement membranes and prominent epithelial cell proliferation (Jones 400×).
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disease with basement membrane abnormalities on EM in 
Alport’s syndrome (Figure 6).
OTHeR HiSTOLOGiCAL vARiANTS OF 
FSGS
Collapsing Glomerulopathy
Collapsing variant of FSGS is characterized by progressive oblit-
eration of capillary lumina due to wrinkling and shrinking of the 
basement membranes (23, 25, 30). It is relatively uncommon in 
children and was originally described in patients with HIV, but 
subsequently also seen in the absence of HIV. Other causes of col-
lapsing glomerulopathy (CG) include infections, such as malaria 
and visceral leishmaniasis, drugs, such as interferon-alpha, 
bisphosphonates, and valproic acid, and autoimmune diseases, 
such as thrombotic microangiopathy and hematologic malignan-
cies (31). They are as a group associated with progressive renal 
failure and have more severe disease at presentation. In children, 
rare forms associated with mitochondrial disorders have been 
reported. The COQ2 mutation is the most common and inherited 
as an autosomal-recessive condition, encoding for para-hydroxy-
benzoate-polyprenyl-transferase enzyme of the CoQ10 synthesis 
pathway (32). The MYH9 gene, an encoding non-muscle myosin 
IIA heavy chain gene, has been implicated in HIV associated CG 
and genetic FSGS in patients of African descent (33). A renal 
biopsy shows characteristic CG with glomerular epithelial cells 
showing abnormal mitochondria. It is important to recognize 
FiGURe 8 | C1q nephropathy. (A,B) Light microscopy showing a low and high magnification images of normal appearing glomeruli in this child with nephrotic 
syndrome. Note one glomerulus in (B) is undergoing normal obsolescence (H&E 100× and 200×). (C) A silver stain showing normal glomeruli with no tubular 
atrophy (Jones 100×). (D) Immunofluorescence for C1q shows a 2+ staining in a mesangial location within a glomerulus. All other stains were negative, including 
C3, IgG, and IgM (DIF 100×). (e,F) Electron micrographs showing open capillary loops with mesangial, paramesangial, and even some subendothelial deposits. 
Note diffuse foot process effacement (3400× and 7100×).
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this variant, as it responds to ubiquinone replacement therapy. 
Histologically, CG is characterized by an implosive collapse of the 
capillary loops with wrinkling and contraction of the basement 
membrane with compensatory hypertrophy and hyperplasia of 
the podocytes, which tend to fill the Bowman’s space resembling 
crescents (Figure 7). There is no endothelial proliferation in this 
condition and no hyaline droplets or lipid is noted. Prominent 
tubulointerstitial changes are a feature. Typically, no significant 
deposits are noted in the membrane besides some IgM and C3. 
EM shows wrinkling with little to no thickening of the basement 
membranes with marked hypertrophy of the overlying podo-
cytes. There is marked foot process effacement involving even 
the glomeruli without the collapsing lesions. In general, patients 
with CG progress rapidly to renal failure and show resistance to 
steroid therapy.
C1q Nephropathy
As mentioned before, the existence of C1q nephropathy as a 
distinct subgroup of NS has been debated. The original descrip-
tion of this entity was by Jennette and Hipp (34). Although 
originally described as a form of FSGS, the histological spectrum 
for C1q nephropathy (Figure 8) could range from MCD to mild 
mesangial proliferation to FSGS (35). The clinical manifestations 
include nephrotic range proteinuria with or without hematuria, 
with hypertension and renal insufficiency in a subset of patients 
(36, 37). Serology is usually negative, and serum C3 and C4 levels 
are normal. Most patients seem to present with steroid-resistant 
NS. The hallmark is presence of strong (2+ and above) staining 
for C1q on IF in a mesangial pattern (35, 38). IgG and/or IgM 
may also be present to some extent as can IgA. EM would show 
features of either MCD or FSGS with some mesangial electron 
dense deposits. The deposits may be predominantly seen in a 
“paramesangial” location. Foot process fusion will also be noted 
(34, 35). The important differential diagnosis to exclude for this 
condition is lupus nephritis and IgA nephropathy. These two 
conditions are distinguished by their distinct immunofluores-
cence pattern and in the case of lupus nephritis with finding 
of tubuloreticular inclusions on EM. A membranoproliferative 
pattern of histology would also not favor a diagnosis of C1q 
nephropathy.
The exact significance of this entity is still debated with its 
relationship to outcome being variable. They do not necessarily 
portend a worse outcome as previously believed with a median 
renal survival in C1q nephropathy/FSGS being about 81 months 
(35). They may be, however, associated with relapses, steroid-
resistant, and steroid-dependent NS (21).
In conclusion, the pathology of podocytopathies have some 
unique and some overlapping features and are frequently associ-
ated with specific genetic mutations. A summary of the patho-
logical findings have been summarized in Table 4 for the reader.
AUTHOR CONTRiBUTiONS
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account of the genetics and pathology of nephrotic syndrome in 
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TABLe 4 | Pathological features of podocytopathies in children.
Diagnosis Light microscopy glomeruli LM tubulointerstitial 
changes
immunofluorescence electron microscopy
CNS Finnish 
type
Normal immature glomeruli early; later 
mesangial increase; sclerosis over time
Early cystic changes in tubules, 
prominent over time. No casts, 
epithelium attenuated
Initial none; later IgM 
and C3
Foot process effacement. No deposits. 
Non-specific
DMS Increased mesangial matrix diffuse; 
segmental sclerosis possible; podocyte 
hyperplasia
Tubular ectasia, small cysts, 
casts, progress to atrophy and 
interstitial fibrosis
IgM and C3 in 
mesangium
Extensive foot process effacement; 
increased mesangial matrix, no deposits.  
BM thickened and lamellated
Minimal change 
Disease (MCD)
Normal appearance of glomeruli, some 
podocyte prominence
Normal Negative Diffuse effacement of foot processes; partial 
if treated
FSGS cellular Segmental hypercellularity – endothelial 
cells, foam cells, and inflammatory cells, 
podocyte hyperplasia – pseudocrescents
Atrophy variable with blood in 
tubules; interstitial inflammation
C3, IgM Foot process effacement restricted. Capillary 
lumina occluded
FSGS NOS Segmental sclerosis, podocyte 
hyperplasia, random distribution of 
sclerotic segment; hyalinosis
Atrophy with interstitial 
inflammation and fibrosis 
variable
C3 and IgM Foot process effacement in region of 
sclerosis. No deposits usually but small 
paramesangial
FSGS with 
mesangial 
hypercellularity
Segmental sclerosis, mesangial 
hypercellularity of non-sclerotic glomeruli
Tubular atrophy and interstitial 
fibrosis
IgM and C3 in sclerosis 
and diffusely in 
mesangium
Extensive podocyte effacement segmental. 
No deposits
Collapsing 
glomerulopathy
Diffuse basement membrane wrinkling with 
collapse of capillary BM with obliteration of 
lumina, diffuse podocyte hyperplasia
Extensive, atrophy, interstitial 
inflammation, edema, fibrosis, 
tubular regeneration
IgM, C3 Wrinkling of BM, podocyte prominence, foot 
process effacement. Rare paramesangial 
deposits, tubuloreticular inclusions only in HIV
C1q 
nephropathy
Normal or FSGS Normal or tubular atrophy. 
Variable interstitial changes
C1q at least 2+; IgG, 
IgM, C3
Mesangial and paramesangial deposits; rare 
subendothelial, foot process effacement
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